ArticleProtein engineering, design & selection : PEDS2025
Enzyme-substrate co-display on yeast empowers engineering of tobacco etch virus protease activity.
Article in Protein engineering, design & selection : PEDS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Megascale recombination generates millions of catalytically competent PETases.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Engineering improved protease activity using directed evolution is challenged by uncertainty in sequence-function mapping and inefficiency in evaluating activity of candidate mutants. We implemented a generalizable yeast surface display approach that co-displays protease mutants with substrate on the same Aga2 anchor protein. Identification of enhanced activity mutants is enabled by protease cleavage of tethered substrate removing an N-terminal epitope tag, which empowers flow cytometric isolation of cells with a decrease in signal from fluorophore-linked anti-epitope antibodies. The sequence space of tobacco etch virus protease (TEVp), commonly used for specific cleavage of recombinant protein affinity tags, has previously been investigated through random mutagenesis. Leveraging our display platform, we performed high throughput screens on seven active site combinatorial libraries created via saturation mutagenesis. Beneficial mutations were incorporated into a single second-generation library, which was screened to identify individual beneficial mutations that performed optimally in a multi-mutant context. The vast majority of resultant TEVp multi-mutants improved catalytic efficiency, generally by decreasing KM. The yeast surface protease/substrate co-display system, the insights gleaned on rational library design and mutation combination strategy, and the TEVp sequence-function map will aid future protease engineering efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.